Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Squaric Acid Dibutylester Treatment of Melanocytes in Congenital Melanocytic Nevi

NCT04999631 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04999631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04999631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Squaric Acid Dibutylester Treatment of Melanocytes in Congenital Melanocytic Nevi
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
June 1, 2030
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congenital melanocytic nevus